J.M. Banales, V. Cardinale, G. Carpino, M. Marzioni, J.B. Andersen, P. Invernizzi, G.E. Lind, T. Folseraas, S.J. Forbes, L. Fouassier, A. Geier, D.F. Calvisi, J.C. Mertens, M. Trauner, A. Benedetti, L. Maroni, J. Vaquero, R.I. Macias, C. Raggi, M.J. Perugorria, E. Gaudio, K.M. Boberg, J.J. Marin, D. Alvaro, Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat. Rev. Gastroenterol. Hepatol. 13, 261–280 (2016). https://doi.org/10.1038/nrgastro.2016.51
S. Rizvi, G.J. Gores, Emerging molecular therapeutic targets for cholangiocarcinoma. J. Hepatol. 67, 632–644 (2017). https://doi.org/10.1016/j.jhep.2017.03.026
B. Flinders, L.R.S. Huizing, M. van Heerden, F. Cuyckens, U.P. Neumann, L.J.W. van der Laan, S.W.M. OldeDamink, R.M.A. Heeren, F.G. Schaap, R.J. Vreeken, Cross-species molecular imaging of bile salts and lipids in liver: identification of molecular structural markers in health and disease. Anal. Chem. 90, 11835–11846 (2018). https://doi.org/10.1021/acs.analchem.8b01378
S. Xiao, C.V. Finkielstein, D.G. Capelluto, The enigmatic role of sulfatides: new insights into cellular functions and mechanisms of protein recognition. Adv. Exp. Med. Biol. 991, 27–40 (2013). https://doi.org/10.1007/978-94-007-6331-9_3
J. Suchanski, J. Grzegrzolka, T. Owczarek, P. Pasikowski, A. Piotrowska, B. Kocbach, A. Nowak, P. Dziegiel, A. Wojnar, M. Ugorski, Sulfatide decreases the resistance to stress-induced apoptosis and increases P-selectin-mediated adhesion: a two-edged sword in breast cancer progression. Breast Cancer Res. 20, 133 (2018). https://doi.org/10.1186/s13058-018-1058-z
T. Takahashi, T. Suzuki, Role of sulfatide in normal and pathological cells and tissues. J. Lipid Res. 53, 1437–1450 (2012). https://doi.org/10.1194/jlr.R026682
M.M. Grimsrud, T. Folseraas, Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis. Liver Int. 39, 2230–2237 (2019). https://doi.org/10.1111/liv.14180
R. Nganga, N. Oleinik, B. Ogretmen, Mechanisms of ceramide-dependent cancer cell death. Adv. Cancer Res. 140, 1–25 (2018). https://doi.org/10.1016/bs.acr.2018.04.007
K. Moro, T. Kawaguchi, J. Tsuchida, E. Gabriel, Q. Qi, L. Yan, T. Wakai, K. Takabe, M. Nagahashi, Ceramide species are elevated in human breast cancer and are associated with less aggressiveness. Oncotarget 9, 19874–19890 (2018). https://doi.org/10.18632/oncotarget.24903
F. Aoudjit, K. Vuori, Integrin signaling in cancer cell survival and chemoresistance. Chemother. Res. Pract. 2012, 283181–283181 (2012). https://doi.org/10.1155/2012/283181
E.J. Salustiano, K.M. da Costa, L. Freire-de-Lima, L. Mendonça-Previato, J.O. Previato, Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias. J. Biol. Chem. 295, 6457–6471 (2020). https://doi.org/10.1074/jbc.RA120.013090
C.M. Robinson, B.P.K. Poon, Y. Kano, F.G. Pluthero, W.H.A. Kahr, M. Ohh, A hypoxia-inducible HIF1-GAL3ST1-sulfatide axis enhances ccRCC immune evasion via increased tumor cell-platelet binding. Mol. Cancer Res. 17, 2306–2317 (2019). https://doi.org/10.1158/1541-7786.Mcr-19-0461
K. Honke, M. Tsuda, Y. Hirahara, N. Miyao, T. Tsukamoto, M. Satoh, Y. Wada, Cancer-associated expression of glycolipid sulfotransferase gene in human renal cell carcinoma cells. Cancer Res. 58, 3800–3805 (1998)
I.C. Kim, G. Bang, J.H. Lee, K.P. Kim, Y.H. Kim, H.K. Kim, J. Chung, Low C24-OH and C22-OH sulfatides in human renal cell carcinoma. J. Mass Spectrom. 49, 409–416 (2014). https://doi.org/10.1002/jms.3358
N. Sakakibara, S. Gasa, K. Kamio, A. Makita, T. Koyanagi, Association of elevated sulfatides and sulfotransferase activities with human renal cell carcinoma. Cancer Res. 49, 335–339 (1989)
A. Silsirivanit, C. Phoomak, K. Teeravirote, S. Wattanavises, W. Seubwai, C. Saengboonmee, Z. Zhan, J.I. Inokuchi, A. Suzuki, S. Wongkham, Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1–h23:0) with shorter survival of the patients. Glycoconj. J. 36, 103–111 (2019). https://doi.org/10.1007/s10719-019-09864-4
N. OgrincPotocnik, T. Porta, M. Becker, R.M. Heeren, S.R. Ellis, Use of advantageous, volatile matrices enabled by next-generation high-speed matrix-assisted laser desorption/ionization time-of-flight imaging employing a scanning laser beam. Rapid. Commun. Mass Spectrom. 29, 2195–2203 (2015). https://doi.org/10.1002/rcm.7379
S.O. Deininger, D.S. Cornett, R. Paape, M. Becker, C. Pineau, S. Rauser, A. Walch, E. Wolski, Normalization in MALDI-TOF imaging datasets of proteins: practical considerations. Anal. Bioanal. Chem. 401, 167–181 (2011). https://doi.org/10.1007/s00216-011-4929-z
M.B. Comisarow, A.G. Marshall, Fourier transform ion cyclotron resonance spectroscopy. Chem. Phys. Lett. 25, 282–283 (1974). https://doi.org/10.1016/0009-2614(74)89137-2
S.R. Kronewitter, M.L. De Leoz, J.S. Strum, H.J. An, L.M. Dimapasoc, A. Guerrero, S. Miyamoto, C.B. Lebrilla, G.S. Leiserowitz, The glycolyzer: automated glycan annotation software for high performance mass spectrometry and its application to ovarian cancer glycan biomarker discovery. Proteomics 12, 2523–2538 (2012). https://doi.org/10.1002/pmic.201100273
M. Levy, A.H. Futerman, Mammalian ceramide synthases. IUBMB Life 62, 347–356 (2010). https://doi.org/10.1002/iub.319
N. Scaglia, J.W. Chisholm, R.A. Igal, Inhibition of StearoylCoA Desaturase-1 inactivates Acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK. PLoS ONE 4, e6812 (2009). https://doi.org/10.1371/journal.pone.0006812
Z. Tracz-Gaszewska, P. Dobrzyn, Stearoyl-CoA desaturase 1 as a therapeutic target for the treatment of cancer. Cancers (Basel) 11, (2019). https://doi.org/10.3390/cancers11070948
A. Daemen, D. Peterson, N. Sahu, R. McCord, X. Du, B. Liu, K. Kowanetz, R. Hong, J. Moffat, M. Gao, A. Boudreau, R. Mroue, L. Corson, T. O’Brien, J. Qing, D. Sampath, M. Merchant, R. Yauch, G. Manning, J. Settleman, G. Hatzivassiliou, M. Evangelista, Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors. Proc. Natl. Acad. Sci. U. S. A. 112, E4410-4417 (2015). https://doi.org/10.1073/pnas.1501605112
M.M. Siddique, Y. Li, B. Chaurasia, V.A. Kaddai, S.A. Summers, Dihydroceramides: from bit players to lead actors. J. Biol. Chem. 290, 15371–15379 (2015). https://doi.org/10.1074/jbc.R115.653204
S. Gerbig, O. Golf, J. Balog, J. Denes, Z. Baranyai, A. Zarand, E. Raso, J. Timar, Z. Takats, Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging. Anal. Bioanal. Chem. 403, 2315–2325 (2012). https://doi.org/10.1007/s00216-012-5841-x
H. Morichika, Y. Hamanaka, T. Tai, I. Ishizuka, Sulfatides as a predictive factor of lymph node metastasis in patients with colorectal adenocarcinoma. Cancer 78, 43–47 (1996). https://doi.org/10.1002/(sici)1097-0142(19960701)78:1%3c43::Aid-cncr8%3e3.0.Co;2-i
Y. Liu, Y. Chen, A. Momin, R. Shaner, E. Wang, N.J. Bowen, L.V. Matyunina, L.D. Walker, J.F. McDonald, M.C. Sullards, A.H. Merrill Jr., Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry. Mol. Cancer 9, 186 (2010). https://doi.org/10.1186/1476-4598-9-186
S. Porubsky, M. Nientiedt, M.C. Kriegmair, J.H. Siemoneit, R. Sandhoff, R. Jennemann, H. Borgmann, T. Gaiser, C.A. Weis, P. Erben, T. Hielscher, Z.V. Popovic, The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma. Sci. Rep. 11, 10926 (2021). https://doi.org/10.1038/s41598-021-90381-6
X. Dai, S. Zhang, H. Cheng, D. Cai, X. Chen, Z. Huang, FA2H exhibits tumor suppressive roles on breast cancers via cancer stemness control. Front. Oncol. 9, 1089 (2019). https://doi.org/10.3389/fonc.2019.01089
H. Hama, Fatty acid 2-Hydroxylation in mammalian sphingolipid biology. Biochim. Biophys. Acta 1801, 405–414 (2010). https://doi.org/10.1016/j.bbalip.2009.12.004
A.B. Herrero, A.M. Astudillo, M.A. Balboa, C. Cuevas, J. Balsinde, S. Moreno, Levels of SCS7/FA2H-mediated fatty acid 2-hydroxylation determine the sensitivity of cells to antitumor PM02734. Cancer Res. 68, 9779–9787 (2008). https://doi.org/10.1158/0008-5472.Can-08-1981
A.M. Lemay, O. Courtemanche, T.A. Couttas, G. Jamsari, A. Gagné, Y. Bossé, P. Joubert, A.S. Don, D. Marsolais, High FA2H and UGT8 transcript levels predict hydroxylated hexosylceramide accumulation in lung adenocarcinoma. J. Lipid Res. 60, 1776–1786 (2019). https://doi.org/10.1194/jlr.M093955
M. Ugorski, P. Påhlsson, D. Dus, B. Nilsson, C. Radzikowski, Glycosphingolipids of human urothelial cell lines with different grades of transformation. Glycoconj. J. 6, 303–318 (1989). https://doi.org/10.1007/bf01047850
Y. Yao, X. Yang, L. Sun, S. Sun, X. Huang, D. Zhou, T. Li, W. Zhang, N.A. Abumrad, X. Zhu, S. He, X. Su, Fatty acid 2-hydroxylation inhibits tumor growth and increases sensitivity to cisplatin in gastric cancer. EBioMedicine 41, 256–267 (2019). https://doi.org/10.1016/j.ebiom.2019.01.066
L. Sun, X. Yang, X. Huang, Y. Yao, X. Wei, S. Yang, D. Zhou, W. Zhang, Z. Long, X. Xu, X. Zhu, S. He, X. Su, 2-Hydroxylation of fatty acids represses colorectal tumorigenesis and metastasis via the YAP transcriptional axis. Cancer Res. 81, 289–302 (2021). https://doi.org/10.1158/0008-5472.Can-20-1517
J. Bridgewater, P.R. Galle, S.A. Khan, J.M. Llovet, J.W. Park, T. Patel, T.M. Pawlik, G.J. Gores, Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J. Hepatol. 60, 1268–1289 (2014). https://doi.org/10.1016/j.jhep.2014.01.021
M. Komuta, Histological heterogeneity of primary liver cancers: clinical relevance, diagnostic pitfalls and the pathologist's role. Cancers (Basel) 13, (2021). https://doi.org/10.3390/cancers13122871
Y.W. Dong, R. Wang, Q.Q. Cai, B. Qi, W. Wu, Y.H. Zhang, X.Z. Wu, Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells. J. Hepatol. 60, 792–801 (2014). https://doi.org/10.1016/j.jhep.2013.12.004
Q. Cao, X. Chen, X. Wu, R. Liao, P. Huang, Y. Tan, L. Wang, G. Ren, J. Huang, C. Dong, Inhibition of UGT8 suppresses basal-like breast cancer progression by attenuating sulfatide-αVβ5 axis. J. Exp. Med. 215, 1679–1692 (2018). https://doi.org/10.1084/jem.20172048
留言 (0)